74 related articles for article (PubMed ID: 15020790)
1. SH3 domain protein-binding arrays.
Chamnongpol S; Li X
Methods Mol Biol; 2004; 264():183-9. PubMed ID: 15020790
[TBL] [Abstract][Full Text] [Related]
2. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
Yamabhai M; Kay BK
Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
[TBL] [Abstract][Full Text] [Related]
3. SH2 domain-based tyrosine phosphorylation array.
Jiang X; Roth L; Han S; Li X
Methods Mol Biol; 2008; 441():153-61. PubMed ID: 18370317
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
Wu C; Ma MH; Brown KR; Geisler M; Li L; Tzeng E; Jia CY; Jurisica I; Li SS
Proteomics; 2007 Jun; 7(11):1775-85. PubMed ID: 17474147
[TBL] [Abstract][Full Text] [Related]
5. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
6. The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction.
Lim CS; Seet BT; Ingham RJ; Gish G; Matskova L; Winberg G; Ernberg I; Pawson T
Biochemistry; 2007 Sep; 46(35):9874-85. PubMed ID: 17696407
[TBL] [Abstract][Full Text] [Related]
7. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
8. Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.
Thalappilly S; Suliman M; Gayet O; Soubeyran P; Hermant A; Lecine P; Iovanna JL; Dusetti NJ
Proteomics; 2008 Aug; 8(15):3071-81. PubMed ID: 18654987
[TBL] [Abstract][Full Text] [Related]
9. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
10. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-, 6- and 7-substituted-2-aminoquinolines as SH3 domain ligands.
Inglis S; Jones R; Fritz D; Stojkoski C; Booker G; Pyke S
Org Biomol Chem; 2005 Jul; 3(14):2543-57. PubMed ID: 15999186
[TBL] [Abstract][Full Text] [Related]
12. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands.
Tran T; Hoffmann S; Wiesehan K; Jonas E; Luge C; Aladag A; Willbold D
Biochemistry; 2005 Nov; 44(45):15042-52. PubMed ID: 16274251
[TBL] [Abstract][Full Text] [Related]
13. 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.
Ruzza P; Siligardi G; Donella-Deana A; Calderan A; Hussain R; Rubini C; Cesaro L; Osler A; Guiotto A; Pinna LA; Borin G
J Pept Sci; 2006 Jul; 12(7):462-71. PubMed ID: 16506148
[TBL] [Abstract][Full Text] [Related]
14. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
15. Protein microarray assay for the screening of SH3 domain interactions.
Asbach B; Kolb M; Liss M; Wagner R; Schäferling M
Anal Bioanal Chem; 2010 Nov; 398(5):1937-46. PubMed ID: 20859618
[TBL] [Abstract][Full Text] [Related]
16. The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex.
Candel AM; Conejero-Lara F; Martinez JC; van Nuland NA; Bruix M
FEBS Lett; 2007 Feb; 581(4):687-92. PubMed ID: 17275816
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases.
Monteiro AN
Biochimie; 2006 Jul; 88(7):905-11. PubMed ID: 16546311
[TBL] [Abstract][Full Text] [Related]
19. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
20. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
